Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

General Population Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases (UNISCREEN): Feasibility and Acceptability Pilot Study.

NCT05841719 is registered in ClinicalTrials.gov with Emanuele Bosi as lead sponsor.

NCT NCT05841719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05841719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
General Population Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases (UNISCREEN): Feasibility and Acceptability Pilot Study.
Lead sponsor
Emanuele Bosi
Phase
Not applicable
Overall status
Completed
Start date
April 22, 2023
Completion date
January 1, 2024
Enrollment
1,535 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, cardiovascular risk factors